市场调查报告书
商品编码
1452942
全球医疗保健延展实境市场 2024-2031Global Healthcare Extended Reality Market 2024-2031 |
全球医疗保健扩展现实市场预计在预测期内(2024-2031 年)将以 16.2% 的CAGR成长。最近的全球健康危机尤其加剧了对远距医疗咨询的需求不断增长,对先进培训方法的需求以及医疗机构对极限编程(XP)技术的投资不断增加是推动市场成长的一些主要因素。此外,远距医疗技术的进步正在对医疗保健领域的扩展现实领域产生积极影响。然而,由于设备成本高且缺乏医疗保健环境中使用的标准化法规,市场也面临挑战。
全球医疗保健扩展现实市场按组件、技术、应用程式和最终用户进行细分。根据组件,市场分为软体和服务以及硬体。根据技术,市场分为 AR、VR 和 MR。根据应用,市场细分为医疗培训和教育、手术规划、復健和治疗以及患者护理和监测。此外,根据最终用户,市场细分为医院、诊所和外科中心、製药和生物技术公司、研究组织和诊断实验室以及政府和国防机构。在最终用户中,医院、诊所和外科中心细分市场预计将占据相当大的市场份额。考虑到医疗流程和患者互动的范围和多样性,扩展现实技术提供了显着的好处。这提高了手术准确性,加快了诊断过程,并提高了患者参与度。医疗保健组织对扩展现实技术的投资将在未来几年内成长,进一步巩固其作为主要最终用户的角色。
在这些技术中,AR细分市场预计将在医疗保健扩展现实市场中占据相当大的份额。 AR 对于需要即时资料迭加的手术(例如手术和诊断)变得越来越重要。它为医疗保健提供者提供了降低风险和减轻认知负担等好处。头戴式显示器和智慧眼镜等穿戴式技术透过在工人完成活动时向他们提供资料和虚拟指令,提供了一种免持工作方式。透过使用 AR 技术可以提高医疗流程的效率,因为基于 AR 的影像视觉化可以帮助外科医生并提高复杂手术期间的准确性和精确度。例如,2023 年 12 月,Augmedics 宣布有 5,000 名患者接受了 xvision 脊椎系统治疗。两者都是第一个获得 FDA 手术批准的 AR 导航系统,也是第一个在美国用于手术的 AR 导航系统。
全球医疗保健扩展现实市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于医疗基础设施的改善,预计亚太地区将在全球市场中占据显着份额。中国、印度和日本等新兴经济体为医疗保健产业 AR 和 VR 技术的开发和分销相关的外包服务提供了相当吸引人的选择。
在所有地区中,由于北美地区强大的医疗基础设施、研发活动投资、有利的政府倡议以及对技术的大量投资,预计北美地区在预测期内将以相当大的CAGR增长。此外,该地区领先的扩展现实和医疗保健技术公司的存在也促进了市场的成长。用于神经外科和胸腔外科的先进 VR 工具,使外科医生能够在执行手术之前虚拟地探索患者的大脑和身体。它使外科医生能够在执行手术之前虚拟地探索患者的解剖结构。此外,VR 是一种较新的分散注意力的形式,可能已在儿科环境中使用,以减轻接受针静脉注射手术的儿童的疼痛和恐惧。例如,加拿大圣地兄弟会儿童医院经过四年的研究,于 2023 年 3 月将 VR 融入其护理流程。这种互动技术的使用使孩子们可以在接受医疗手术时使用虚拟现实,减少他们可能经历的焦虑或疼痛。透过持续努力,医院可以在 2024 年为约 3,500 名患者提供 VR,并在未来 5 年内为多达 17,500 名患者提供 VR。
服务于全球医疗保健扩展现实市场的主要公司包括索尼公司、Magic Leap、美敦力、Surgical Theater, Inc.、Osso VR、AppliedVR、BioflightVR、Fundamentalurgery、Fusion VR、GIGXR、Medicalholodeck、PrecisionOS、SphereGen Technologies LLC、XRHealth Technologies LLC、XR、PrecisionOS和别的。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2021 年 1 月,Hologic, Inc. 以约 2.3 亿美元收购了 Biotheranostics, Inc.,这是一家私人持有的商业阶段公司,为乳腺癌和转移性癌症提供分子诊断测试。透过收购 Biotheranostics,Hologic, Inc. 可能会将其合资企业推向规模庞大且迅速扩张的肿瘤学领域,这与其更大的公司目标一致。
Global Healthcare Extended Reality Market Size, Share & Trends Analysis Report by Component (Software & Services and Hardware), by Technology (Augmented Reality (AR), Virtual Reality (VR), and Mixed Reality (MR)), and by Application (Medical Training and Education, Surgical Planning, Rehabilitation & Therapy, and Patient Care & Monitoring), and by End-User (Hospitals, Clinics & Surgical Centers, Pharmaceutical & Biotechnology Companies, Research Organization & Diagnostics Laboratories, and Government & Defense Institutions) Forecast Period (2024-2031)
The global healthcare extended reality market is anticipated to grow at a CAGR of 16.2% during the forecast period (2024-2031). The rising need for remote medical consultations is especially accentuated by recent global health crises, the need for advanced training methods, and the growing investments in Extreme Programming (XP) technology by healthcare organizations are some of the major factors contributing to the market growth. Additionally, advances in telemedicine technologies are positively affecting the extended reality sector within healthcare. However, the market also faces challenges due to the high cost of devices and the lack of standardized regulations for their use in healthcare settings.
The global healthcare extended reality market is segmented by component, technology, application, and end-user. Based on the component, the market is sub-segmented into software & services, and hardware. Based on the technology, the market is sub-segmented into AR, VR, and MR. Based on the applications, the market is sub-segmented into medical training and education, surgical planning, rehabilitation and therapy, and patient care & monitoring. Further, based on the end-users, the market is sub-segmented into hospitals, clinics & surgical centers, pharmaceutical & biotechnology companies, research organizations and diagnostics laboratories, and government & defense institutions. Among the end-users, the hospitals, clinics, and surgical centers sub-segment is anticipated to hold a considerable share of the market. Extended reality technologies provide significant benefits considering the scope and diversity of medical processes and patient interactions. This increases surgical accuracy, expedites diagnostic processes, and improves patient engagement. Investments in extended reality technologies by healthcare organizations are set to grow in the coming years, further solidifying their role as the primary end-users.
Among the technology, the AR sub-segment is expected to hold a considerable share of the healthcare extended reality market. AR is becoming increasingly crucial for procedures that require real-time overlays of data, such as surgeries and diagnostics. It offers benefits such as reduced risk and less cognitive load for healthcare providers. Wearable technology, such as head-mounted displays and smart glasses, provide a hands-free approach to perform work by providing data and virtual instructions to workers as they complete activities. The efficiency of healthcare processes can be enhanced by using AR technologies as AR-based image visualization assists surgeons and enhances their accuracy and precision during complex surgeries. For instance, in December 2023, Augmedics announced 5,000 patients treated with its xvision Spine System. Both were the first AR navigation systems to gain FDA approval for surgery and the first to be used in surgery in the US.
The global healthcare extended reality market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the improving healthcare infrastructure. Emerging economies such as China, India and Japan present attractive options for outsourcing services associated with the development and distribution of AR and VR technology in the healthcare industry.
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period due to its robust healthcare infrastructure, investment in R&D activities, favorable government initiatives, and significant investments in technology. Additionally, the presence of leading extended reality and healthcare technology companies in the region boosting the market growth. Advanced VR tool for neurosurgery and thoracic surgery, enables surgeons to virtually explore a patient's brain and body before performing a procedure. It enables surgeons to virtually explore a patient's anatomy prior to performing a procedure. Furthermore, VR is a more recent form of distraction that may have been used in the pediatric setting for reducing pain and fear in children undergoing needle-based intravenous procedures. For instance, in March 2023, Shriners Hospitals for Children Canada integrated VR into its care processes after four years of research. The use of this interactive technology allows children to use VR, while undergoing medical procedures reducing anxiety or pain they may experience. With sustained efforts, the hospitals could offer VR to approximately 3,500 patients in 2024 and up to 17,500 patients over the next 5 years.
The major companies serving the global healthcare extended reality market include Sony Corporation, Magic Leap, Medtronic, Surgical Theater, Inc., Osso VR, AppliedVR, BioflightVR, Fundamental Surgery, Fusion VR, GIGXR, Medicalholodeck, PrecisionOS, SphereGen Technologies LLC, XRHealth, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2021, Hologic, Inc. acquired Biotheranostics, Inc., a privately held, commercial-stage Company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million. By acquiring Biotheranostics, Hologic, Inc. may launch its venture into a sizable and rapidly expanding oncology adjacency, which aligns with their larger company objectives.